Antidepressant use and risk of adverse outcomes in older people: population based cohort study

Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., Hippisley-Cox, J.·2011·BMJ

Cited by (830)

Items 201–300 of 830

  1. Association between depression and the risk for fracture: a meta-analysis and systematic review
    Lei Qiu, Qin Yang, Na Sun, Dandan Li, Yuxin Zhao, Xiaotong Li, Yanhong Gong, Chuanzhu Lv, Xiaoxv Yin · 2018 · BMC Psychiatry
  2. Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population–Based Case–Control Study
    Henrik Falhammar, Jakob Skov, Jan Calissendorff, David Nathanson, Jonatan D. Lindh, Buster Mannheimer · 2020 · The Journal of Clinical Endocrinology & Metabolism
  3. Incidence of antidepressant use in community‐dwelling persons with and without Alzheimer's disease: 13‐year follow‐up
    Arto Puranen, Heidi T. Taipale, Marjaana Koponen, Antti J. Tanskanen, Anna‐Maija Tolppanen, Jari Tiihonen, Sirpa A. Hartikainen · 2016 · International Journal of Geriatric Psychiatry
  4. Chinese perspectives on primary care for common mental disorders: Barriers and policy implications
    Sun, Kai Sing, Lam, Tai Pong, Wu, Dan · 2018 · International Journal of Social Psychiatry
  5. Association between Antidepressants and Fall-Related Injuries among Long-Term Care Residents
    Jennifer C. Macri, Andrea Iaboni, Julia G. Kirkham, Colleen Jean Maxwell, Sudeep S. Gill, Akshya Vasudev, Marlo Whitehead, Dallas Peter Seitz · 2017 · American Journal of Geriatric Psychiatry
  6. Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study
    Carlotta Lunghi, Ippazio Cosimo Antonazzo, Sofia Burato, Emanuel Raschi, Violetta Zoffoli, Emanuele Forcesi, Elisa Sangiorgi, Marco Menchetti, Pasquale Roberge, Elisabetta Poluzzi · 2020 · Neuropsychiatric Disease and Treatment
  7. Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients
    Tara V. Anand, Brendan K. Wallace, Herbert S Chase · 2021 · BMC Geriatrics
  8. Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark
    Kazi Ishtiak‐Ahmed, Katherine Louise Musliner, Kaj Sparle Christensen, Erik Lykke Mortensen, Andrew Alan Nierenberg, Christiane Gasse · 2023 · American Journal of Psychiatry
  9. The Use of Antidepressants in Belgian Nursing Homes
    Jolyce Bourgeois, Monique M. Elseviers, Luc M. Van Bortel, Mirko Petrović, Robert Vander Stichele · 2012 · Drugs & Aging
  10. Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan
    Then, Chee-Kin, Chi, Nai-Fang, Chung, Kuo-Hsuan, Kuo, Lynn, Liu, Kao-Hui, Hu, Chaur-Jong, Shen, Shing-Chuan, Lin, Yen-Kuang · 2017 · PLOS ONE
  11. Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study
    Raymond Noordam, Nikkie Aarts, Maarten J.G. Leening, Henning W. Tiemeier, Oscar H. Franco, Albert Hofman D, Bruno H. Ch. Stricker, Loes E. Visser · 2015 · European Journal of Clinical Pharmacology
  12. Perceived need for treatment and non-utilization of outpatient psychotherapy in old age: two cohorts of a nationwide survey
    Paul R. Gellert, Sonia Lech, Eva‐Marie Kessler, Wolfram Herrmann, Susanne Döpfmer, Klaus Balke, Monika Oedekoven, Adelheid Kuhlmey, Susanne Schnitzer · 2021 · BMC Health Services Research
  13. Carotid Artery Stiffness and Incident Depressive Symptoms: The Paris Prospective Study III
    Thomas T. van Sloten, Pierre Boutouyrie, Muriel Tafflet, Lucile Offredo, Frédérique Thomas, Catherine Guibout, Rachel E. Climie, Cédric Lemogne, Bruno Pannier, Stéphane Laurent et al. · 2018 · Biological Psychiatry
  14. Depressive Symptoms and the Risk of Ischemic Stroke in the Elderly—Influence of Age and Sex
    Christian Ludwig Seifert, Holger Poppert, Dirk Sander, Regina Feurer, Thorleif Etgen, Karl‐Heinz Ander, Klaus Pürner, Monika Brönner, Dominik Sepp, Victoria Kehl et al. · 2012 · PLoS ONE
  15. Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI
    Hilmar P. Sigurdsson, Gudrun Hefner, Nagia Ben Omar, Anton Köstlbacher, Katharina Wenzel‐Seifert, Christoph Hiemke, Ekkehard Haen · 2014 · Journal of Neural Transmission
  16. Bridging the “digital divide”: A comparison of use and effectiveness of an online intervention for depression between Baby Boomers and Millennials
    Schneider, Brooke C., Schröder, Johanna, Berger, Thomas, Hohagen, Fritz, Meyer, Björn, Späth, Christina, Greiner, Wolfgang, Hautzinger, Martin, Lutz, Wolfgang, Rose, Matthias et al. · 2018 · Journal of Affective Disorders
  17. Fifty years of pharmacovigilance – Medicines safety and public health
    Joan‐Ramon Laporte · 2016 · Pharmacoepidemiology and Drug Safety
  18. Polypharmacy in the elderly
    Anna Cantlay, Tessa Glyn, Natalia Barton · 2016 · InnovAiT Education and inspiration for general practice
  19. Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: A repetitive cross-sectional study in 19 European countries
    Shanquan Chen, Tamsin Jane Ford, Peter Brian Jones, Rudolf N. Cardinal · 2022 · The Lancet Regional Health - Europe
  20. Antidepressants are Independently Associated with Gait Deficits in Single and Dual Task Conditions
    Orna A. Donoghue, Celia O’Hare, Bellinda L. King‐Kallimanis, Rose Anne Kenny · 2014 · American Journal of Geriatric Psychiatry
  21. Helping people discontinue long-term antidepressants: views of health professionals in UK primary care
    Bowers, Hannah M, Williams, Samantha J, Geraghty, Adam W A, Maund, Emma, O’brien, Wendy, Leydon, Geraldine, May, Carl R, Kendrick, Tony · 2019 · BMJ Open
  22. Utilization patterns of antidepressants between 1991 and 2011 in a population-based cohort of middle-aged and elderly
    Aarts, N., Noordam, R., Hofman, A., Tiemeier, H., Stricker, B.H., Visser, L.E. · 2014 · European Psychiatry
  23. Hyponatremia and psychotropics
    Sandeep Grover, Swapnajeet Sahoo · 2016 · Journal of Geriatric Mental Health
  24. The elderly and falls: Factors associated with quality of life A cross-sectional study using large-scale national data in Korea
    Jin‐Won Noh, Kyoung-Beom Kim, Juhyun Lee, Byeong-Hui Lee, Young Dae Kwon, Seon Heui Lee · 2017 · Archives of Gerontology and Geriatrics
  25. Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study
    Henrik Falhammar, Jan Calissendorff, Jakob Skov, David Nathanson, Jonatan D. Lindh, Buster Mannheimer · 2019 · European Journal of Internal Medicine
  26. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study
    Marja-Liisa Laitinen, Eija Lönnroos, J. Simon Bell, Piia Lavikainen, Raimo O. Sulkava, Sirpa A. Hartikainen · 2014 · International Psychogeriatrics
  27. Neuropsychological Deficits Chronically Developed after Focal Ischemic Stroke and Beneficial Effects of Pharmacological Hypothermia in the Mouse
    Zhong Weiwei, Yuan Yan, Xiaohuan Gu, Kim Samuel In-young, Chin Ryan, Loye Modupe, Dix Thomas A, Ling Wei, Yu Shan Ping · 2020 · Aging and Disease
  28. The trouble with antidepressants: why the evidence overplays benefits and underplays risks - an essay by John B Warren
    Warren, John B · 2020 · BMJ
  29. Inhibition of Serotonin Reuptake by Antidepressants and Cerebral Microbleeds in the General Population
    Nikkie Aarts, Saloua Akoudad, Raymond Noordam, Albert Hofman D, M. Arfan Ikram, Bruno H. Ch. Stricker, Loes E. Visser, Meike Willemijn Vernooij · 2014 · Stroke
  30. Antidepressants and the risk of death in older patients with depression: A population-based cohort study
    Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Tania Schink, Edeltraut Garbe, Niklas Schmedt · 2019 · PLoS ONE
  31. Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury
    Jennifer S. Albrecht, Zippora Kiptanui, Yuen Tsang, Bilal Khokhar, Gordon Stephen Smith, Ilene H. Zuckerman, Jane M. Simoni · 2014 · Journal of Neurotrauma
  32. Potentially inappropriate medications and drug–drug interactions in home‐dwelling people with mild dementia
    Ragnhild Oesterhus, Dag Aarsland, Hogne Soennesyn, Arvid Rongve, Geir Selbæk, Svein Reidar Kjosavik · 2016 · International Journal of Geriatric Psychiatry
  33. Falls: The Adverse Drug Reaction of the Elderly and the Impact of Pharmacogenetics
    Katja Susanne Just, Katharina Luise Schneider, Marlen Schurig, Julia Stingl, Jürgen Brockmöller · 2017 · Pharmacogenomics
  34. Post Stroke Depression Frequently Overlooked, Undiagnosed, Untreated
    Sabrina Kamil Dar, Hema Venigalla, Ali Mahmood Khan, Rizwan Ahmed, Hema Madhuri Mekala, Hira Zain, Shanila Shagufta · 2017 · Neuropsychiatry
  35. Long-term antidepressant use in general practice: a qualitative study of GPs’ views on discontinuation
    Maria Donald, Riitta L Partanen, Leah S. Sharman, Johanna M. Lynch, Genevieve A. Dingle, Catherine Haslam, Mieke van Driel · 2021 · British Journal of General Practice
  36. Drugs that lower the seizure threshold
    Andrew William Hitchings · 2016 · Adverse Drug Reaction Bulletin
  37. Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials
    Siegfried F. Kasper · 2015 · Wiener Medizinische Wochenschrift
  38. Fall and Fracture Risk in Nursing Home Residents With Moderate-to-Severe Behavioral Symptoms of Alzheimer’s Disease and Related Dementias Initiating Antidepressants or Antipsychotics
    Yu‐Jung Jenny Wei, Jane M. Simoni, Judith A. Lucas, Nicole Brandt · 2016 · The Journals of Gerontology Series A
  39. Antidepressant use and risk of hip fractures among community‐dwelling persons with and without Alzheimer's disease
    Sanna Torvinen‐Kiiskinen, Anna‐Maija Tolppanen, Marjaana Koponen, Antti J. Tanskanen, Jari Tiihonen, Sirpa A. Hartikainen, Heidi T. Taipale · 2017 · International Journal of Geriatric Psychiatry
  40. Changes in prevalence of psychotropic drug use and alcohol consumption among the elderly in Germany: results of two National Health Interview and examination surveys 1997–99 and 2008–11
    Wolf, Ingrid-Katharina, Du, Yong, Knopf, Hildtraud · 2017 · BMC Psychiatry
  41. The relationship between syncope, depression and anti-depressant use in older adults
    Bhangu, Jaspreet S., King-Kallimanis, Bellinda, Cunningham, Conal, Kenny, Rose Anne · 2014 · Age and Ageing
  42. Traditional Chinese herbal medicines for the treatment of ischemic stroke in China
    Xiaomeng Dong, Tianya Zhang, Cong Zhang, Wenyan Shang, Yuqing Zhang, Xiangjian Zhang · 2025 · Ageing Research Reviews
  43. The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications
    James Davies, Ruth E Cooper, Joanna Moncrieff, Luke Montagu, Todd C. Rae, Mamata Parhi · 2021 · Addictive Behaviors
  44. Risk of Fall-Related Injuries Associated with Antidepressant Use in Elderly Patients: A Nationwide Matched Cohort Study
    Yu-Seon Jung, David Suh, Hangseok Choi, Hee-Deok Park, Sun‐Young Jung, Dong‐Churl Suh · 2022 · International Journal of Environmental Research and Public Health
  45. Multimorbidity and depressive symptoms in older adults and the role of social support: Evidence using Canadian Longitudinal Study on Aging (CLSA) data
    Lixia Zhang, Shahin Shooshtari, Philip St. John, Verena H. Menec · 2022 · PLoS ONE
  46. Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients
    J. Mortensen, G. Andersen · 2015 · Expert Opinion on Drug Safety
  47. Antidepressant-like effects of ginseng fruit saponin in myocardial infarction mice
    Meiyan Liu, Jianyang Liu, Lijun Zhang, Qingshan Geng, Yingbin Ge · 2019 · Biomedicine & Pharmacotherapy
  48. Antidepressant Medication Use and Its Association With Cardiovascular Disease and All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
    Hansen, Richard A., Khodneva, Yulia, Glasser, Stephen P., Qian, Jingjing, Redmond, Nicole, Safford, Monika M. · 2016 · Annals of Pharmacotherapy
  49. The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use
    David M. Taylor, Sofia Poulou, Ivana Clark · 2024 · Therapeutic Advances in Psychopharmacology
  50. Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study
    Ha Young Jang, Jae Hyun Kim, Yun-Kyoung Song, Ju‐Young Shin, Hae‐Young Lee, Yong Min Ahn, Jung Mi Oh, In‐Wha Kim · 2020 · Frontiers in Pharmacology
  51. Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribing
    James Davies, John Read, Danny Kruger, Nigel Crisp, Norman Lamb, Michael Dixon, Sam Everington, Sheila C. Hollins, Joanna Moncrieff, Bogdan Chiva Giurca et al. · 2023 · BMJ
  52. The natural history of depression and trajectories of symptoms long term after stroke: The prospective south London stroke register
    Salma A. Ayis, Luis Ayerbe, Siobhan L. Crichton, Anthony George Rudd, Charles D.A. Wolfe · 2016 · Journal of Affective Disorders
  53. GENETIC MODERATORS OF THE IMPACT OF PHYSICAL ACTIVITY ON DEPRESSIVE SYMPTOMS
    Vonetta M. Dotson, F C Hsu, Taimour Yousef Langaee, Caitrin W. McDonough, Abby C. King, Ronald A. Cohen, Anne B. Newman, Stephen B. Kritchevsky, Vicki Myers, Todd Matthew Manini et al. · 2016 · The Journal of Frailty & Aging
  54. Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort
    Isabelle Carrière, A. Farré, Joanna L. Norton, Marilyn Wyart, Christophe Tzourio, Pernelle Noïze, Karine Pérès, Annie Fourrier‐Réglat, Marie‐Laure Ancelin · 2016 · Osteoporosis International
  55. Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing?
    Stephen John Ralph, Anthony J. Espinet · 2017 · Dementia
  56. Trends in treatment for patients with depression in general practice in Norway, 2009–2015: nationwide registry-based cohort study (The Norwegian GP-DEP Study)
    Sabine Ruths, Inger Haukenes, Øystein Hetlevik, Tone Smith‐Sivertsen, Stefán Hjörleifsson, Anneli Borge Hansen, Sharline Riiser, Heidi Marie Meling, Valborg Baste · 2021 · BMC Health Services Research
  57. The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy
    Gudrun Hefner, AK Laib, Hilmar P. Sigurdsson, Matthias Hohner, Christoph Hiemke · 2013 · International Review of Psychiatry
  58. Risk of incident cardiovascular events amongst individuals with anxiety and depression: A prospective cohort study in the east London primary care database
    Rohini Mathur, María Pérez-Piñar, Quintí Foguet Boreu, Salma A. Ayis, Luis Ayerbe · 2016 · Journal of Affective Disorders
  59. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication
    Robyn M Tamblyn, David Westfall Bates, David Llewellyn Buckeridge, William Gregory Dixon, Nadyne Girard, Jennifer S. Haas, Bettina Habib, Usman Iqbal, Jack Li, Thérèse Sheppard · 2020 · Journal of the American Geriatrics Society
  60. REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial
    Tony Kendrick, Adam W A Geraghty, Hannah M. Bowers, Beth L. Stuart, Geraldine Leydon, Carl R May, Guiqing Yao, Wendy O’Brien, Marta Głowacka, Simone Holley et al. · 2020 · Trials
  61. Antidepressiva zur Behandlung der Depression bei Palliativpatienten
    Mariam Ujeyl, Bruno Müller-Oerlinghausen · 2012 · Der Schmerz
  62. Increasing enjoyable activities to treat depression in nursing home residents with dementia: a pilot study
    Travers, Catherine · 2017 · Dementia
  63. Quality of Psychopharmacological Medication Prescribing and Mortality in Medicare Beneficiaries in Nursing Homes
    Yu‐Jung Jenny Wei, Linda Simoni‐Wastila, Ilene H. Zuckerman, TING-YING JANE HUANG, Nicole Brandt, Patience Moyo, Judith A. Lucas · 2014 · Journal of the American Geriatrics Society
  64. Managing Falls in Older Patients with Cognitive Impairment
    Morag E. Taylor, Kim Delbaere, Jacqueline Close, Stephen R. Lord · 2012 · Aging Health
  65. Depression and dementia
    Eleanor M Curran, Samantha M. Loi · 2013 · The Medical Journal of Australia
  66. Age-related changes in the antidepressant-like effect of desipramine and fluoxetine in the rat forced-swim test
    Maribel Olivares-Nazario, Alonso Fernández‐Guasti, Lucı́a Martı́nez-Mota · 2015 · Behavioural Pharmacology
  67. Review of treatment for late-life depression
    Charlotte L. Allan, Klaus P. Ebmeier · 2013 · Advances in Psychiatric Treatment
  68. Dementia-Related Agitation
    John Edward Morley · 2011 · Journal of the American Medical Directors Association
  69. Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) – Sex differences and associations with morbidity and medication use
    Sarah Toepfer, Juliane Bolbrinker, Maximilian König, Elisabeth Steinhagen‐Thiessen, Reinhold Hugo Kreutz, Ilja Demuth · 2019 · PLoS ONE
  70. Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristics
    Martin F. Fromm, Renke Maas, Thomas Tümena, Karl‐Günter Gaßmann · 2012 · European Journal of Clinical Pharmacology
  71. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study
    B. A. Perry, Kristin R. Archer, Yun‐Kyoung Song, Yunsheng Ma, J. K. Green, Florent Elefteriou, Kathryn McCrystal Dahir · 2016 · Osteoporosis International
  72. The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
    Ted Rosenberg, Rory Lattimer, Patrick R. Montgomery, Christian Wiens, Liran Levy · 2017 · Clinical Interventions in Aging
  73. Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population‐based cohort study
    Masao Iwagami, Laurie A. Tomlinson, Kathryn Elizabeth Mansfield, Ian Douglas, Liam L Smeeth, Dorothea Nitsch · 2018 · British Journal of Clinical Pharmacology
  74. Explanatory factors for the association between depression and long-term physical disability after stroke
    Luis Ayerbe, Salma A. Ayis, Siobhan L. Crichton, Anthony George Rudd, Charles D.A. Wolfe · 2015 · Age and Ageing
  75. Antidepressants and Hyponatremia
    Yeong-Hau Howard Lien · 2017 · The American Journal of Medicine
  76. Adherence to antidepressant therapy and mortality rates in ischaemic heart disease: cohort study
    Amir Krivoy, Ran D. Balicer, Becca Feldman, Moshe Hoshen, Gil Zalsman, Abraham Weizman, Gal Shoval · 2015 · The British Journal of Psychiatry
  77. Effects of psychopharmacological treatment with antidepressants on the vascular system
    Kai G. Kahl, Mechthild Westhoff‐Bleck, Tillmann H. C. Krüger · 2017 · Vascular Pharmacology
  78. QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients
    Gudrun Hefner, Martina Hahn, Matthias Hohner, S Roll, Ansgar Klimke, Christoph Hiemke · 2018 · Pharmacopsychiatry
  79. The overprescription of antidepressants and its impact on the elderly in Australia
    Muath Alduhishy · 2018 · Trends in Psychiatry and Psychotherapy
  80. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system
    Kai G. Kahl · 2018 · Hormone Molecular Biology and Clinical Investigation
  81. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
    Duffy, Larisa, Bacon, Faye, Clarke, Caroline S., Donkor, Yvonne, Freemantle, Nick, Gilbody, Simon, Hunter, Rachael, Kendrick, Tony, Kessler, David, King, Michael et al. · 2019 · Trials
  82. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT
    Martin S. Dennis, John Forbes, Catriona Graham, Maree Lisa Hackett, Graeme J. Hankey, Allan O. House, Steff C. Lewis, Erik Lundström, Peter AG Sandercock, Gillian Elizabeth Mead · 2020 · Health Technology Assessment
  83. Exploring depression in Alzheimer’s disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management
    Alessandro Padovani, Angelo Antonini, Paolo Barone, Giuseppe Bellelli, Andrea M. Fagiolini, Luigi Ferini‐Strambi, Sandro Sorbi, Fabrizio Stocchi · 2023 · Neurological Sciences
  84. Internet and Telephone Support for Discontinuing Long-Term Antidepressants
    Tony Kendrick, Beth L. Stuart, Hannah M. Bowers, Mahboobeh Haji Sadeghi, Page Hl, Christopher F Dowrick, Michael V Moore, Mark Gabbay, Geraldine Leydon, Guiqing Yao et al. · 2024 · JAMA Network Open
  85. Use of Falls Risk Increasing Drugs in Residents at High and Low Falls Risk in Aged Care Services
    Kate Wang, J. Simon Bell, Julia Gilmartin‐Thomas, Edwin C.K. Tan, Tina Cooper, Leonie Robson, Jenni Ilomäki · 2019 · Journal of Applied Gerontology
  86. Antidepressants and the serotonin hypothesis of depression
    Tony Kendrick, Susan Collinson · 2022 · BMJ
  87. Small-scale implementation with pragmatic process evaluation: a model developed in primary health care
    Kirsti Malterud, Aase Aamland, Kristina Riis Iden · 2018 · BMC Family Practice
  88. From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy
    Arzoo Singh Pannu, Ramesh K. Goyal · 2024 · Current Drug Safety
  89. Pharmaco-epidemiology of antidepressant exposure in a UK cohort record-linkage study
    Jonathan D. Hafferty, Eleanor M. Wigmore, David M. Howard, Mark J. Adams, Toni‐Kim Clarke, Archie Campbell, Donald J. MacIntyre, Kristin K. Nicodemus, Stephen M. Lawrie, David John Porteous et al. · 2019 · Journal of Psychopharmacology
  90. Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia
    Buster Mannheimer, Henrik Falhammar, Jan Calissendorff, Jakob Skov, Jonatan D. Lindh · 2021 · Journal of Psychopharmacology
  91. Prevalence, Patterns, and Predictors of Depression Treatment among Community-Dwelling Elderly Individuals with Dementia in the United States
    Sandipan Bhattacharjee, Yeum Mok Oh, Eric M. Reiman, W. J. Burke · 2017 · American Journal of Geriatric Psychiatry
  92. Cognitive behavioural therapy and third-wave approaches for anxiety and related disorders in older people
    Gert‐Jan Hendriks, Noortje Janssen, Lindsay Robertson, Anton J.L.M. van Balkom, Willeke H. van Zelst, Samantha Wolfe, Richard C. Oude Voshaar, Eleonora Uphoff · 2024 · Cochrane Database of Systematic Reviews
  93. Drug-induced hyponatremia in clinical care
    Buster Mannheimer, Jonatan D. Lindh, Cecilia Fahlén Bergh, Issa Issa, Henrik Falhammar, Jakob Skov · 2025 · European Journal of Internal Medicine
  94. Person-Centered Suicide Prevention
    Paul R. Duberstein, Marsha Nicole Wittink · 2015 · Elsevier eBooks
  95. Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling
    Céline Miani, Adam Martin, Josephine Exley, Brett Doble, Ed Wilson, Rupert Payne, Anthony John Avery, Catherine Meads, Anne Kirtley, Molly Morgan Jones et al. · 2017 · Health Technology Assessment
  96. Xingnao Jieyu Decoction Ameliorates Poststroke Depression through the BDNF/ERK/CREB Pathway in Rats
    Tao Li, Dou Wang, Bing Zhao, Yongmei Yan · 2018 · Evidence-based Complementary and Alternative Medicine
  97. Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
    Monica L. Mathys · 2018 · Mental Health Clinician
  98. Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study
    Wiebke Schäfer, Christina Princk, Bianca Kollhorst, Tania Schink · 2019 · Drug Safety
  99. Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and Bleeding
    Joris J. Komen, Paul Hjemdahl, Aukje Kaija Mantel-Teeuwisse, Olaf H. Klungel, Björn Wettermark, Tomas Forslund · 2019 · Clinical Pharmacology & Therapeutics
  100. Psychotropic Medication Effects on Seizure Threshold and Seizure Duration During Electroconvulsive Therapy Stimulus Titration
    Stephanie Chiao, Keith E. Isenberg, Carol S. North · 2019 · Journal of Ect